Evaluation of RSDL, M291 SDK, 0.5% Bleach, 1% Soapy Water and SERPACWA. Part 1: Challenge with VX
Abstract
There is a need for Joint forces to effectively operate across the continuum of global contingency operations. The requirement exists for a pre-exposure barrier skin cream to increase the efficacy of the protective suit and for the ability to decontaminate the skin, individual equipment, and casualties, including those with wounds that have been exposed to chemical, biological, radiological, and nuclear (CBRN) warfare agents. Current doctrine describes the use of Skin Exposure Reduction Paste Against Chemical Warfare Agents (SERPACWA) as a barrier skin cream and the M291 Skin Decontamination Kit (SDK), 0.5% hypochlorite solution (household bleach diluted 1 to 10) and 1% soapy water solution to decontaminate intact skin exposed to chemical warfare agents. Reactive Skin Decontamination Lotion (RSDL) is a new product approved by the FDA and selected in March 2007 by the Joint Program Executive Office for Chemical and Biological Defense to eventually replace the M291 SDK. This report, the first in a series, directly compares the efficacy of SERPACWA and the four listed decontamination products in the haired guinea pig model following exposure to VX.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jun 01, 2009
- Accession Number
- ADA525186
Entities
People
- Bryce F. Doxzon
- Edward D. Clarkson
- Ernest H. Braue Jr.
- Horace K. Lumpkin
- Kelly A. Hanssen
Organizations
- United States Army Medical Research Institute of Chemical Defense